Lani Ibarra
Hoofd Techniek/Wetenschap/O&O bij STRUCTURE THERAPEUTICS INC.
Profiel
Lani Ibarra is currently working as the Senior VP-Clinical Development Operations at Structure Therapeutics, Inc. Previously, Lani held positions as the Vice President-Clinical Operations at Dynavax Technologies Corp., Vice President-Global Clinical Operations at Molecular Partners AG, and Vice President-Global Clinical Operations at Molecular Partners,.
Inc. Lani obtained a graduate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.
Actieve functies van Lani Ibarra
Bedrijven | Functie | Begin |
---|---|---|
STRUCTURE THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Lani Ibarra
Bedrijven | Functie | Einde |
---|---|---|
MOLECULAR PARTNERS AG | Hoofd Techniek/Wetenschap/O&O | - |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Corporate Officer/Principal | - |
DYNAVAX TECHNOLOGIES CORPORATION | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Lani Ibarra
Stanford University | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
STRUCTURE THERAPEUTICS INC. | Commercial Services |
MOLECULAR PARTNERS AG | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |